Resource Center
Resource Center
Aurobindo Pharma Limited is pleased to announce the tentative approval of Dolutegravir 50mg from US Food & Drug Administration (USFDA) for the treatment of HIV. This important milestone marks the first FDA approval of a generic version of Dolutegravir (DTG), an integrase strand transfer inhibitor recommended for use in treatment-naïve patients by the US...
Read moreIn Kanchin State, a remote part of northern Myanmar, 24 year-old U Dee Se has used heroin since the age of 18. Like many other people who inject drugs (PWIDs) in the area, throughout his drug use, he shared needles with friends, but was unconcerned about potentially contracting HIV. “My body was asking for the...
Read moreIn September 2015, a group of family doctors and primary care clinic staff gathered in the southern Ukranian city of Kriviy Rih to attend a provider support group-sponsored training on integrated HIV care for injection drug users at the Center of Excellence Psychiatric Dispensary. Here in Kriviy Rih, a city with an injection drug user...
Read more(Boston, MA, April 13, 2016) – The Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares, with the aid of a multi-year product-donation from Bristol-Myers Squibb, have initiated a first-of-its-kind program in Africa and Asia aimed at curing hepatitis C (HCV) among patients co-infected with HCV and human immunodeficiency virus (HIV). Bristol-Myers Squibb has agreed to...
Read moreCHAI supports national governments to expand high-quality care and treatment to people living with HIV/AIDS. CHAI negotiates reduced prices for antiretrovirals (ARVs) on behalf of members of its procurement consortium. See the 2015 CHAI ARV Reference Price List here.
Read moreFor Immediate Release Contact: press@clintonhealthaccess.org Becton Dickinson partners with the Clinton Health Access Initiative, Inc. (CHAI) to implement an innovative CD4 Access Solution Rethinking the Role of Diagnostics Suppliers in Public Health 18 December 2015 – Becton Dickinson (BD), the leading provider of CD4 testing solutions in sub-Saharan Africa, is partnering with ministries of health,...
Read moreToday, on World AIDS Day, we recognize the significant progress that has been made in the fight against HIV/AIDS. In mid-2015, UNAIDS announced that the global goal of putting 15 million HIV-infected patients on treatment by 2015 had been reached nine months in advance of the deadline. With a view toward the goal of ending...
Read moreThese agreements have the potential to increase access to state-of-the-art HIV treatment regimens for people living with HIV in low- and middle- income countries.
Read moreCHAI’s ARV Market Report provides a global perspective on the ARV marketplace in low- and middle-income countries in 2014 and outlines CHAI’s expectations on how the market will evolve over the next five years. See the 2015 ARV Market Report here.
Read moreThe Clinton Health Access Initiative, Inc. (CHAI) and the Ministry of Health of Zambia announce the release of new evidence regarding the integration of infant HIV testing with routine immunization services. Early testing of HIV-exposed infants and the initiation of antiretroviral therapy for HIV-positive infants is critical to improving infant survival. While Zambia has made...
Read more